Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GSK
MRNA
Add up to 3 more stocks
GSK
GSK plc
-0.83%
$49.24-0.41Delayed quote: Sep 25, 2026, 4:00 PM EDT
Market Cap
$98.65B
52W Range
$39.29 - $61.70
MRNA
Moderna, Inc.
+2.08%
$198.88+4.06Delayed quote: Sep 25, 2026, 4:00 PM EDT
Market Cap
$78.91B
52W Range
$22.28 - $176.66
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 15.57 | N/A |
| Forward P/E | N/A | N/A |
| P/B Ratio | 4.24 | 11.67 |
| P/S Ratio | 2.23 | 35.42 |
| P/FCF Ratio | 10.58 | N/A |
| EV/EBITDA | 7.97 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 72.7% | 55.4% |
| Operating Margin | 20.7% | -158.1% |
| Net Margin | 14.5% | -141.4% |
| ROE | 27.7% | -46.6% |
| ROA | 7.9% | -28.8% |
| ROIC | 13.9% | -39.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.82 | 2.29 |
| Quick Ratio | 0.52 | 2.18 |
| Debt/Equity | 1.03 | 0.19 |
| Interest Coverage | 12.14 | -307.40 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 3.8% | N/A |
| Payout Ratio | 57.5% | N/A |
| Yrs of Dividend Growth | 2 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.